Veozah dosage · All 50 States

Veozah (fezolinetant) dosage and liver-test schedule

Veozah (fezolinetant) dosage: 45 mg once daily, liver tests before treatment, monthly for three months and at months 6 and 9, plus interactions and when to stop.

Start your visit →

← Hormone replacement therapy pillar

DIRECT ANSWER

Veozah is a single fixed dose: one 45 mg tablet once daily, with or without food. There is no titration. It carries a boxed warning for liver injury, so liver blood tests are required before starting, monthly for the first three months, then at months 6 and 9. Stop and contact your clinician for symptoms such as yellowing skin, dark urine or upper-right abdominal pain.

Dosage chart

Strength / step	How it is used	Labeled detail	When clinicians use it	Watch for
45 mg once daily	Tablet, same time daily	Only labeled dose	Moderate-to-severe menopausal hot flashes	No dose adjustment option
Baseline liver tests	Before first dose	Required	Everyone	Abnormal results may rule it out
Months 1, 2, 3, 6, 9	Follow-up liver tests	Per current label	Everyone on treatment	Lab visits needed

Strengths shown are from current U.S. labeling, for context only. Your clinician sets your dose based on your history.

RxNorm drug identifiers

RxNorm is the U.S. National Library of Medicine's standard naming system for medicines. These codes link each product to its official record.

Name	Concept type	RxCUI
Fezolinetant	Ingredient	2637134
Veozah	Brand name	2637142

How clinicians actually choose

Review medications for CYP1A2 inhibitors, which are contraindicated.
Cirrhosis and severe kidney impairment are reasons not to use it.
Missed dose: take it as soon as remembered the same day; do not double up.

Frequently asked questions

Is there a lower Veozah dose?

No. 45 mg once daily is the only labeled dose.

How quickly does Veozah work?

Trials showed reductions in hot flash frequency within the first weeks, with effects measured at 4 and 12 weeks.

Do I need liver tests forever?

The label specifies tests through month 9, and anytime symptoms suggest liver problems.

More dosage guides

Veozah vs Lynkuet →Fezolinetant guide →Lynkuet dosage →Estradiol patch dosage →Oral estradiol dosage →Estradiol gel dosage →Progesterone dosage →Vaginal estrogen dosage →Lynkuet dosage →Paroxetine 7.5 mg dosage →

Not sure which option is right for you?

A board-certified clinician licensed in your state reviews your intake within one business day and recommends the route that fits your history — not a template.

Start your visit →

Comparing providers first? How to choose an HRT telehealth provider →

WRITTEN & MEDICALLY REVIEWED BY

Kindr Health Clinical Team

Kindr Health Inc. — Editorial & Clinical Team, led by Kevin Wolfe, CMO

Kindr’s clinical content is written and reviewed by board-certified clinicians who prescribe hormone therapy every day across all 50 states — menopause-focused physicians, nurse practitioners, and pharmacists working under Kindr Health, Inc.’s organizational clinical oversight. Every page is checked against current NAMS and ACOG guidance, FDA labeling, and the primary literature before publication, then re-reviewed on a rolling schedule when guidance changes.

Organizational NPI 1609792902 · Last reviewed July 3, 2026 · Editorial policy

Educational content only — not a substitute for individual medical advice, diagnosis, or treatment.

SOURCES & REFERENCES

Every clinical claim on this page is sourced.

The 2022 Hormone Therapy Position Statement of The North American Menopause Society (2022) — The North American Menopause Society (NAMS). www.menopause.org/docs/default-source/professional/nams-2022-hormone-therapy-position-statement.pdf
Clinical Practice Guideline: Treatment of Menopause-Associated Vasomotor Symptoms (2023) — American College of Obstetricians and Gynecologists (ACOG). www.acog.org/clinical/clinical-guidance/clinical-practice-guideline
Menopause and hormone therapy: menopausal symptoms and treatments — NIH Office on Women’s Health. www.womenshealth.gov/menopause
Menopausal Hormone Therapy and Cancer Risk — National Cancer Institute (NIH). www.cancer.gov/about-cancer/causes-prevention/risk/hormones/mht-fact-sheet
Estradiol — drug label and prescribing information — U.S. Food & Drug Administration, DailyMed / NLM. dailymed.nlm.nih.gov/dailymed

Information on this page is for educational purposes only. Prescription medications require clinical evaluation and provider approval. Individual results vary. Not an emergency service.